Abstract
BACKGROUND
In the current laparoscopic surgery practice of colorectal cancer (CRC), the four-port technique is more traumatic, whereas the single-port surgery is associated with technical difficulty and a limited field of view. Thus, the two-port technique, which is less traumatic and more feasible, becomes increasingly significant in clinical practice.
AIM
To compare the clinical effects of two-port and four-port laparoscopic techniques for CRC treatment.
METHODS
In the review of the medical records of patients with CRC from March 2022 to March 2025, 80 cases of two-port laparoscopic radical resection (two-port group) and 70 cases of four-port laparoscopic resection (four-port group) were identified for direct surgical comparison. These groups were evaluated and compared for surgical indicators (surgical duration, total intraoperative hemorrhage, and total length of incision), postoperative recovery (time to first flatus/ambulation, and total hospitalization duration), postoperative complications (ileus, anastomotic fistula, surgical site infection, bleeding, uroschesis, and intraperitoneal abscess), gastrointestinal function (gastrin and motilin), oncological indices (carcinoembryonic antigen, cytokeratin 19 fragment antigen 21-1, and carbohydrate antigen 125), and humoral immunity [immunoglobulin (Ig) A/G/M].
RESULTS
The two-port and four-port groups were comparable in terms of operation time and total intraoperative bleeding. However, the two-port group showed lower values with respect to the total incision length, time to flatus/ambulation, hospitalization time, and overall complications. Gastrin and motilin levels were reduced from baseline in the two-port group but were still higher than those in the four-port group. Carcinoembryonic antigen, cytokeratin 19 fragment antigen 21-1, and carbohydrate antigen 125 levels were lower, whereas IgA, IgG, and IgM values were higher postoperatively in the two-port group than those in the four-port group.
CONCLUSION
Compared with patients with CRC who underwent four-port laparoscopic surgery, those who underwent two-port laparoscopic resection recovered faster and were fairly safe. In addition, the gastrointestinal hormone disturbance was relatively mild, the serum tumor markers were significantly reduced, and the humoral immune response was enhanced.
Keywords: Two-port technique, Four-port technique, Laparoscopic radical resection, Colorectal cancer, Clinical outcomes
Core Tip: This study compares the efficacy of two-port with that of four-port laparoscopic radical resection of colorectal cancer. The two-port approach shows clinical superiority, with reduced total incision length, quicker postoperative recovery, fewer total complications, and better gastrointestinal/humoral immune functions. The results can provide better surgical treatment options for patients with colorectal cancer.
INTRODUCTION
Colorectal cancer (CRC) is a fatal and multifactorial tumor disease. Sedentary lifestyles, smoking, obesity, spicy diet, alcohol abuse, and other factors may increase the risk of CRC[1,2]. As the third most common tumor globally, CRC is likely to occur in high-income countries, such as Europe, North America, and Australia, while presenting a low risk in low-income countries[3]. The pathological mechanism of CRC is related to mucosal inflammation. Continuous inflammation on epithelial proliferation can easily induce cancerization. Moreover, abnormal conditions, such as oxidative damage and DNA double-strand breaks, can further increase the risk of carcinogenesis[4]. Laparoscopic surgery is a curative treatment for CRC. Compared with open surgery, it reduces bleeding, promotes recovery, and reduces complications[5]. Traditional laparoscopic surgery in patients with CRC often requires placing 4 and 5 surgical ports, which may cause concurrent wound infection and greater damage to organs, hindering therapeutic effects[6,7]. The single-port technique often has limited clinical applications because of increased operative complexity, small surgical field of view, and prolonged operation time[8]. Thus, the two-port laparoscopic approach was developed based on a single-port to widen the operating field and reduce surgical complexity[9]. However, few relevant studies and reports have investigated its application to patients with CRC.
Based on the above background, this study attempted to evaluate the clinical effects of two-port in comparison with four-port laparoscopic surgery for CRC from a multidimensional perspective to provide new insights to optimize the surgical outcomes of patients with CRC. The results are clinically significant to further improve the medical experience of these patients.
MATERIALS AND METHODS
Study population
From March 2022 to March 2025, 150 patients with CRC admitted to the study hospital were selected. The patients were divided according to the treatment method: (1) 80 patients who underwent two-port laparoscopic resection for CRC (two-port group); and (2) 70 patients who received four-port laparoscopic surgical treatment (four-port group). The sample size calculation did not rely on precalculated statistical power but was based on selecting eligible patients with CRC treated between March 2022 and March 2025.
Case selection and exclusion parameters
The eligibility requirements were as follows: (1) Diagnosis of CRC[10]; (2) Age 18-80 years; (3) Stage I-III disease[11]; (4) First-time surgical candidates for laparoscopic radical surgery; and (5) Complete medical data.
The exclusion criteria were as follows: (1) Other malignancies; (2) Recent endocrine, chemotherapy, or radiotherapy treatment; (3) Severe immunosuppressive status; (4) Abdominal operation history; (5) Organic (cardiac, cerebral, pulmonary, hepatic, or renal) diseases; (6) Peritonitis, intestinal obstruction, or perforation; (7) Cognitive/communicative defects; and (8) American Association of Anesthesiologists score > III[12].
Treatment methods
Patients in the two-port group underwent two-port laparoscopic radical resection for CRC. Briefly, patients were placed in the lithotomy position, and general anesthesia was administered via endotracheal intubation. Following routine disinfection and dressing, a 2-3 cm incision was made on the left side of the patient’s navel. The skin and tissues were incised, which served as the auxiliary operation port. An artificial CO2 pneumoperitoneum was established, and a Trocar was inserted approximately two fingers’ width from the anterior superior iliac spine on the right side, which served as the main operation port. After visualizing the lesion with the laparoscope, the tumor was resected: The right pararectal sulcus was incised, revealing the left Toldt, which was expanded. The inferior mesenteric artery lymph nodes were cleared, and a ligature was applied approximately 1 cm from the root of the ligament. The ligament of the inferior mesenteric vein was expanded outward at the same level. The sigmoid colon was freed, ensuring protection of the ureters and pelvic nerve plexus. Subsequently, the retrorectal, lateral, and anterior spaces were dissected. After the tumor was removed, the intestinal tube was disconnected to complete the resection. The resected tissue was placed in a specimen bag. The incision was sutured to achieve hemostasis, a drainage tube was then placed, and the abdominal cavity was closed.
The four-port group underwent four-port laparoscopic surgery as follows: Patients were placed in the lithotomy position, and general anesthesia was induced through tracheal intubation. A 100-mm Trocar was inserted at the upper edge of the navel as the main observation port. The location of the main operation port was the same as that in the two-port group. A secondary operation port was placed on the right side, and the assistant operation port was located at the midpoint of the line connecting the navel and the left anterior superior iliac spine. An auxiliary incision measuring 6-8 cm was made in the middle of the lower part of the umbilicus. Subsequent procedures, including specimen extraction, drainage tube placement, and intestinal anastomosis, were performed identically to the two-port technique.
Endpoints
Operative measures: This included surgical duration, intraoperative hemorrhage volume, and cumulative incision length in each cohort.
Postoperative recovery: This included the time to first flatus, ambulation initiation, and hospital stay duration.
Complications: Patients were monitored for ileus, anastomotic fistula, surgical site infection (SSI), postoperative bleeding, uroschesis, and intraperitoneal abscess, with their frequency rates computed.
Gastrointestinal function markers: Specifically, 5-mL fasting venous blood was obtained during morning hours before surgical intervention and after a 30-day recovery. Centrifuged serum specimens were subjected to radioimmunological determination of gastrin (GAS) and motilin (MT) concentrations.
Oncological biomarkers: Serum carcinoembryonic antigen (CEA), cytokeratin 19 fragment antigen 21-1 (Cyfra 21-1), and carbohydrate antigen 125 (CA125) were assessed using automated immunoassay systems before surgery and 1 month after surgery.
Humoral immunity: Preoperative and postoperative (1 month) serum immunoglobulin (Ig) A/G/M measurements were performed by turbidimetric immunoassay.
Statistical analysis
In this study, quantitative data deviating from a normal distribution are expressed as the median (interquartile range) [M(Q1, Q3)]. Normally distributed quantitative data are presented as mean ± SD. Between-group differences for quantitative variables were examined through independent t-tests, whereas within-group changes (e.g., preoperative vs postoperative measurements) were analyzed using paired t-tests. Categorical variables, summarized as n (%), were subjected to χ² tests to determine group differences. IBM SPSS Statistics version 5.0 facilitated all computations, with significance indicated by P < 0.05.
RESULTS
Patient demographics
The intergroup comparison (Table 1) showed comparable baseline patient features (e.g., sex, age, body mass index, tumor, node, metastasis stage, lesion location, and tumor diameter; P > 0.05).
Table 1.
Patient baseline information, n (%)/mean ± SD
|
General data
|
Two-port group (n = 80)
|
Four-port group (n = 70)
|
χ
2/Z/t
|
P value
|
| Sex | 0.058 | 0.809 | ||
| Male | 45 (56.25) | 38 (54.29) | ||
| Female | 35 (43.75) | 32 (45.71) | ||
| Age (years) | 57.20 ± 7.30 | 59.29 ± 9.21 | 1.549 | 0.124 |
| Body mass index (kg/m2) | 22.00 (20.00, 24.00) | 22.00 (20.00, 25.00) | -0.195 | 0.845 |
| Tumor, node, metastasis stage | 1.306 | 0.520 | ||
| I | 24 (30.00) | 17 (24.29) | ||
| II | 22 (27.50) | 25 (35.71) | ||
| III | 34 (42.50) | 28 (40.00) | ||
| Lesion location | 0.076 | 0.782 | ||
| Colon cancer | 52 (65.00) | 47 (67.14) | ||
| Rectal cancer | 28 (35.00) | 23 (32.86) | ||
| Tumor diameter (cm) | 4.09 ± 1.24 | 3.83 ± 1.39 | 1.211 | 0.228 |
Operative measure comparison
The two groups were comparable with respect to surgical duration and intraoperative hemorrhage volume (P > 0.05). However, the two-port group exhibited a smaller cumulative incision length than the four-port group (P < 0.001; Table 2).
Table 2.
Comparative operative measures, mean ± SD
|
Operative measures
|
Two-port group (n = 80)
|
Four-port group (n = 70)
|
t value
|
P value
|
| Surgical duration (minutes) | 99.69 ± 13.85 | 103.07 ± 17.51 | 1.319 | 0.189 |
| Intraoperative hemorrhage volume (mL) | 28.27 ± 8.53 | 30.63 ± 10.85 | 1.489 | 0.139 |
| Cumulative incision length (cm) | 5.58 ± 0.80 | 8.96 ± 1.20 | 20.520 | < 0.001 |
Postoperative recovery
The two-port group had shorter time to first flatus/ambulation and shorter hospital stays than the four-port group (P < 0.001; Table 3).
Table 3.
Postoperative recovery comparison, mean ± SD
|
Postoperative recovery indexes
|
Two-port group (n = 80)
|
Four-port group (n = 70)
|
t value
|
P value
|
| Time to first flatus (hours) | 46.64 ± 7.98 | 65.54 ± 10.67 | 12.376 | < 0.001 |
| Ambulation initiation (hours) | 29.52 ± 7.97 | 35.11 ± 10.05 | 3.795 | < 0.001 |
| Hospital stays duration (days) | 8.46 ± 1.76 | 10.66 ± 2.39 | 6.470 | < 0.001 |
Complications
Table 4 summarizes the postoperative complication rates. The rates of ileus, anastomotic fistula, SSI, postoperative bleeding, uroschesis, and intraperitoneal abscess were lower in the two-port group than in the four-port group (P = 0.019).
Table 4.
Complications across study groups, n (%)
|
Complications
|
Two-port group (n = 80)
|
Four-port group (n = 70)
|
χ
2
|
P value
|
| Ileus | 0 (0.00) | 1 (1.43) | ||
| Anastomotic fistula | 2 (2.50) | 2 (2.86) | ||
| Surgical site infection | 1 (1.25) | 3 (4.29) | ||
| Postoperative bleeding | 0 (0.00) | 2 (2.86) | ||
| Uroschesis | 2 (2.50) | 5 (7.14) | ||
| Intraperitoneal abscess | 3 (3.75) | 4 (5.71) | ||
| Total | 8 (10.00) | 17 (24.29) | 5.486 | 0.019 |
Gastrointestinal function markers
The preoperative values for all gastrointestinal (GI) function markers (GAS and MT) were comparable across the study groups (P > 0.05; Figure 1). Postoperatively, all values decreased markedly (all P < 0.001); however, the two-port approach maintained superior GAS and MT concentrations relative to the four-port technique (all P < 0.001).
Figure 1.
Comparative gastrointestinal function markers. A: Preoperative/postoperative gastrin level changes; B: Preoperative/postoperative motilin level alterations. aP < 0.05, bP < 0.01 for intra-group vs preoperative; cP < 0.05 for inter-group comparison at same time point. GAS: Gastrin; MT: Motilin.
Serum oncological biomarkers of the two patient groups
Figure 2 demonstrates comparable preoperative concentrations of CEA, Cyfra 21-1, and CA125 between the two cohorts (P > 0.05). Following surgery, both groups demonstrated significant decreases in all tumor markers (all P < 0.001), with the two-port approach showing superior reduction in CEA (P = 0.004), Cyfra 21-1 (P < 0.001), and CA125 (P < 0.001) concentrations relative to the four-port technique.
Figure 2.
Serum oncological biomarkers in both patient groups. A: Comparative carcinoembryonic antigen levels before and after surgery; B: Preoperative and postoperative cytokeratin 19 fragment antigen 21-1 level variations across groups; C: Carbohydrate antigen 125 variation pre-surgery vs post-surgery. aP < 0.05, bP < 0.01 for within-group vs baseline; cP < 0.05 for inter-group vs four-port. CA125: Carbohydrate antigen 125; CEA: Carcinoembryonic antigen; Cyfra 21-1: Cytokeratin 19 fragment antigen 21-1.
Humoral immunity
Before surgery, IgA, IgG, and IgM measurements did not differ significantly between the groups (P > 0.05). The two-port group had higher postoperative Ig levels than the four-port group (P < 0.001; Figure 3).
Figure 3.
Comparative analysis of humoral immune responses. A: Preoperative and postoperative immunoglobulin (Ig) A dynamics across study cohorts; B: Temporal changes in IgG concentrations (preoperative vs postoperative); C: IgM level variations before and after surgery. bP < 0.01 for within-group preoperative comparisons; cP < 0.05 for between-group differences relative to four-port group at equivalent timepoints. Ig: Immunoglobulin.
DISCUSSION
CRC has high late diagnosis and mortality rates, with considerable geographical differences in the risk of onset and death. Moreover, CRC tends to become more prevalent among younger people in developed countries[13,14]. To prevent and treat CRC and optimize related management, this study tried to compare and analyze the clinical effects of two surgical techniques and seek better solutions for laparoscopic surgical therapy for patients with CRC.
Initially, no significant intergroup variations were found in surgical duration and intraoperative bleeding; however, cumulative incision length was markedly reduced in the two-port group. This finding highlights the advantages of the two-port technique in achieving smaller incisions. Gu et al[15] did not find a significant difference in the operation time and blood loss volume between the single-incision and multi-port laparoscopic surgery for patients with CRC, similar to the results of the present study. Kim et al[16] also did not observe a significant difference in the operation time and intraoperative blood loss between the two-port and four-port laparoscopic techniques in patients undergoing ovarian cystectomy, aligning with our findings.
Moreover, time to first flatus/ambulation and overall hospitalization durations were shorter with the two-port approach, indicating enhanced postoperative recovery. In the study of Jiang et al[17], the two-port laparoscopic approach for patients with sigmoid colon cancer and upper rectal cancer resulted in a shorter total incision length than the four-port laparoscopic approach. This approach also facilitated a shorter time to first ambulation, exhaust, defecation, and liquid diet, which complements the results of this study.
Furthermore, significant reductions were observed in the overall complications (ileus, anastomotic fistula, SSI, postoperative bleeding, uroschesis, and intraperitoneal abscess) in the two-port group. In the study by Wang et al[18], single-incision plus single-port surgery was found to have certain clinical safety and minimally invasive characteristics when applied to patients with colon cancer, supporting the results of the present study. Additionally, Angulo et al[19] reported the higher effectiveness of the two-port than the four-port laparoscopic approach for radical cystectomy in reducing postoperative pain. This finding provides another potential clinical advantage for the clinical application of two-port laparoscopic surgery in CRC.
The postoperative levels of GAS and MT of the two-port group significantly decreased, but were still markedly higher than those in the four-port group, suggesting that the two-port group offered better protection of GI function. GAS and MT, both GI hormones, are closely related to the GI function of patients with CRC undergoing surgery, and can indicate whether patients experienced surgery-related stress[20]. Past evidence revealed markedly downregulated GAS and MT levels in patients with CRC following laparoscopic radical surgery. Hence, higher postoperative GAS and MT levels are indicative of relatively lesser surgical trauma and better GI function recovery[21], which is consistent with the outcomes of the two-port laparoscopic surgeries in the present study. The marked decreases in postoperative CEA, Cyfra21-1, and CA125 levels in the two-port group, lower than those in the four-port group, suggest that the two-port laparoscopic approach is more effective in preventing the progression of CRC. In previous studies, CEA has been shown as a reliable predictor of recurrence and clinical outcomes of laparoscopic radical surgery for CRC. Cyfa 21-1 is the most sensitive biological indicator of patients with recurrent CRC and is closely related to Dukes’ staging. CA125 shows a close connection with CRC outcomes. All three are strongly linked to CRC development[22-24].
The notable postoperative increases in IgA, IgG, and IgM expression in the two-port group in comparison with those in the four-port group support the former’s better performance in enhancing humoral immunity. In patients with CRC, short-term postoperative intervention with abdominal surgery may lead to weakened cellular immune function because of surgical trauma and stress. As patients’ condition improves and GI function enhances, their humoral immune function usually recovers well 1 month after surgery, which is similar to the results of Xu et al[25] and Bohne et al[26].
Several limitations should be noted. First, given the lack of sleep/life quality and adverse mood evaluations, supplementary analyses in these areas can help elucidate the potential advantages of two-port laparoscopic radical resection in CRC. Second, long-term patient outcomes (5-10 years) should be tracked to understand the lasting effects of the two approaches. Finally, a health economic analysis of the two approaches is necessary for the clinical promotion of the two-port technique. These deficiencies will be addressed in future research.
CONCLUSION
The results reveal that for CRC treatment, the two-port laparoscopic radical resection has more clinical merits than the four-port approach. It stands out particularly in shortening the cumulative incision length, boosting postoperative recovery, lowering the total complication rate, safeguarding patients’ GI and humoral immune functions, and curbing disease progression.
Footnotes
Institutional review board statement: This study was approved by the Ethic Committee of the Second Affiliated Hospital of University of South China.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.
Provenance and peer review: Unsolicited article; Externally peer reviewed.
Peer-review model: Single blind
Specialty type: Gastroenterology and hepatology
Country of origin: China
Peer-review report’s classification
Scientific Quality: Grade B
Novelty: Grade C
Creativity or Innovation: Grade B
Scientific Significance: Grade C
P-Reviewer: Narh CT, PhD, France S-Editor: Luo ML L-Editor: A P-Editor: Xu J
Contributor Information
Hong-Xing Xia, Department of Gastrointestinal Surgery, Affiliated Nanhua Hospital, University of South China, Hengyang 421001, Hunan Province, China.
Su Peng, Department of Gastrointestinal Surgery, The Second Affiliated Hospital of University of South China, Hengyang 421001, Hunan Province, China. pengsu1234@126.com.
Data sharing statement
No additional data are available.
References
- 1.Pardamean CI, Sudigyo D, Budiarto A, Mahesworo B, Hidayat AA, Baurley JW, Pardamean B. Changing Colorectal Cancer Trends in Asians: Epidemiology and Risk Factors. Oncol Rev. 2023;17:10576. doi: 10.3389/or.2023.10576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Xu L, Zhao J, Li Z, Sun J, Lu Y, Zhang R, Zhu Y, Ding K, Rudan I, Theodoratou E, Song P, Li X Global Health Epidemiology Research Group (GHERG) National and subnational incidence, mortality and associated factors of colorectal cancer in China: A systematic analysis and modelling study. J Glob Health. 2023;13:04096. doi: 10.7189/jogh.13.04096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Papier K, Bradbury KE, Balkwill A, Barnes I, Smith-Byrne K, Gunter MJ, Berndt SI, Le Marchand L, Wu AH, Peters U, Beral V, Key TJ, Reeves GK. Diet-wide analyses for risk of colorectal cancer: prospective study of 12,251 incident cases among 542,778 women in the UK. Nat Commun. 2025;16:375. doi: 10.1038/s41467-024-55219-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sato Y, Tsujinaka S, Miura T, Kitamura Y, Suzuki H, Shibata C. Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management. Cancers (Basel) 2023;15:4154. doi: 10.3390/cancers15164154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Vilsan J, Maddineni SA, Ahsan N, Mathew M, Chilakuri N, Yadav N, Munoz EJ, Nadeem MA, Abbas K, Razzaq W, Abdin ZU, Ahmed M. Open, Laparoscopic, and Robotic Approaches to Treat Colorectal Cancer: A Comprehensive Review of Literature. Cureus. 2023;15:e38956. doi: 10.7759/cureus.38956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Liu ZM, Yao QJ, Pei F, He F, Zhao Y, Huang J. Efficacy and safety of reduced-port laparoscopic surgery versus conventional laparoscopic surgery for colorectal cancer. BMC Cancer. 2025;25:187. doi: 10.1186/s12885-025-13585-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mostafa OES, Zaman S, Beedham W, Kakaniaris G, Husain N, Kumar L, Akingboye A, Waterland P. Systematic review and meta-analysis comparing outcomes of multi-port versus single-incision laparoscopic surgery (SILS) in Hartmann's reversal. Int J Colorectal Dis. 2024;39:190. doi: 10.1007/s00384-024-04752-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lv C, Wu S, Wu Y, Shi J, Su Y, Fan Y, Kong J, Yu X. Single-incision laparoscopic versus traditional multiport laparoscopic colorectal surgery--a cumulative meta-analysis and systematic review. Int J Colorectal Dis. 2013;28:611–621. doi: 10.1007/s00384-013-1653-5. [DOI] [PubMed] [Google Scholar]
- 9.Yi SW. Postoperative abdominopelvic adhesion and umbilical wound validation after single-port laparoscopy or two-port laparoscopy for gynecological surgery: a comparison with conventional laparoscopy. Arch Gynecol Obstet. 2025;311:1599–1607. doi: 10.1007/s00404-025-07951-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ness RM, Llor X, Abbass MA, Bishu S, Chen CT, Cooper G, Early DS, Friedman M, Fudman D, Giardiello FM, Glaser K, Gurudu S, Hall M, Huang LC, Issaka R, Katona B, Kidambi T, Lazenby AJ, Maratt J, Markowitz AJ, Marsano J, May FP, Mayer RJ, Olortegui K, Patel S, Peter S, Porter LD, Shafi M, Stanich PP, Terdiman J, Vu P, Weiss JM, Wood E, Cassara CJ, Sambandam V. NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024. J Natl Compr Canc Netw. 2024;22:438–446. doi: 10.6004/jnccn.2024.0047. [DOI] [PubMed] [Google Scholar]
- 11.Chizhikova M, López-Úbeda P, Martín-Noguerol T, Díaz-Galiano MC, Ureña-López LA, Luna A, Martín-Valdivia MT. Automatic TNM staging of colorectal cancer radiology reports using pre-trained language models. Comput Methods Programs Biomed. 2025;259:108515. doi: 10.1016/j.cmpb.2024.108515. [DOI] [PubMed] [Google Scholar]
- 12.Matsubara D, Soga K, Ikeda J, Konishi T, Uozumi Y, Takeda R, Kanazawa H, Komatsu S, Shimomura K, Taniguchi F, Shioaki Y, Otsuji E. Laparoscopic Surgery for Elderly Colorectal Cancer Patients With High American Society of Anesthesiologists Scores. Anticancer Res. 2023;43:5637–5644. doi: 10.21873/anticanres.16767. [DOI] [PubMed] [Google Scholar]
- 13.Anugwom C, Braimoh G, Sultan A, Johnson WM, Debes JD, Mohammed A. Epidemiology and genetics of early onset colorectal cancer-African overview with a focus on Ethiopia. Semin Oncol. 2023;50:28–33. doi: 10.1053/j.seminoncol.2023.03.007. [DOI] [PubMed] [Google Scholar]
- 14.Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal Cancer: Epidemiology, Risk Factors, and Prevention. Cancers (Basel) 2024;16:1530. doi: 10.3390/cancers16081530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gu C, Wu Q, Zhang X, Wei M, Wang Z. Single-incision versus conventional multiport laparoscopic surgery for colorectal cancer: a meta-analysis of randomized controlled trials and propensity-score matched studies. Int J Colorectal Dis. 2021;36:1407–1419. doi: 10.1007/s00384-021-03918-6. [DOI] [PubMed] [Google Scholar]
- 16.Kim ML, Song T, Seong SJ, Yoon BS, Joo WD, Jung YW, Kang JH, Jun HS. Comparison of single-port, two-port and four-port laparoscopic surgery for cyst enucleation in benign ovarian cysts. Gynecol Obstet Invest. 2013;76:57–63. doi: 10.1159/000351113. [DOI] [PubMed] [Google Scholar]
- 17.Jiang F, Ji M, Jin F, Liu J, Liu X. Clinical application of two-port laparoscopic surgery in sigmoid colon and upper rectal cancer resection. Front Oncol. 2023;13:1248280. doi: 10.3389/fonc.2023.1248280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wang Y, Deng H, Mou T, Li J, Liu H, Zhou H, Li G. Short-term outcomes of single-incision plus one-port laparoscopic versus conventional laparoscopic surgery for rectosigmoid cancer: a randomized controlled trial. Surg Endosc. 2019;33:840–848. doi: 10.1007/s00464-018-6350-6. [DOI] [PubMed] [Google Scholar]
- 19.Angulo JC, García-Tello A, Mateo E, Gimbernat H, Redondo C, Andrés G. Two-Port Approach Compared to Standard Laparoscopic Radical Cystectomy. J Endourol. 2015;29:1030–1037. doi: 10.1089/end.2015.0161. [DOI] [PubMed] [Google Scholar]
- 20.Li WB, Li J, Yu W, Gao JH. Short-term efficacy of laparoscopic radical resection for colorectal cancer and risk of unplanned reoperation after surgery. World J Gastrointest Surg. 2025;17:102442. doi: 10.4240/wjgs.v17.i4.102442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Liu B, Yao C, Li H. Laparoscopic Radical Resection of Colorectal Cancer in the Treatment of Elderly Colorectal Cancer and Its Effect on Gastrointestinal Function. Front Surg. 2022;9:840461. doi: 10.3389/fsurg.2022.840461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Baqar AR, Wilkins S, Staples M, Angus Lee CH, Oliva K, McMurrick P. The role of preoperative CEA in the management of colorectal cancer: A cohort study from two cancer centres. Int J Surg. 2019;64:10–15. doi: 10.1016/j.ijsu.2019.02.014. [DOI] [PubMed] [Google Scholar]
- 23.Lee JH. Clinical Usefulness of Serum CYFRA 21-1 in Patients with Colorectal Cancer. Nucl Med Mol Imaging. 2013;47:181–187. doi: 10.1007/s13139-013-0218-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Björkman K, Mustonen H, Kaprio T, Kekki H, Pettersson K, Haglund C, Böckelman C. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242. Tumour Biol. 2021;43:57–70. doi: 10.3233/TUB-200069. [DOI] [PubMed] [Google Scholar]
- 25.Xu D, Li J, Song Y, Zhou J, Sun F, Wang J, Duan Y, Hu Y, Liu Y, Wang X, Sun L, Wu L, Ding K. Laparoscopic surgery contributes more to nutritional and immunologic recovery than fast-track care in colorectal cancer. World J Surg Oncol. 2015;13:18. doi: 10.1186/s12957-015-0445-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bohne A, Grundler E, Knüttel H, Fürst A, Völkel V. Influence of Laparoscopic Surgery on Cellular Immunity in Colorectal Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel) 2023;15:3381. doi: 10.3390/cancers15133381. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No additional data are available.



